This page requires Flash Player 8, if this does not play you can download here.
Important Safety Information
Tri-Luma® Cream should be used with measures for sun avoidance, like using strong sunscreens. People allergic to sulfites should not use Tri-Luma® Cream. Tri-Luma® contains hydroquinone, which may cause a gradual blue-black darkening of the skin. Safety and efficacy have not been established in pregnant or nursing women, or individuals with darker skin. HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide. Redness, peeling, burning, dryness and itching may occur. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided.
For more information about Tri-Luma® Cream, see Full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Medwatch, or call 1-800-FDA-1088.
Tri-Luma® Cream should be used with measures for sun avoidance, like using strong sunscreens. People allergic to sulfites should not use Tri-Luma® Cream. Tri-Luma® contains hydroquinone, which may cause a gradual blue-black darkening of the skin. Safety and efficacy have not been established in pregnant or nursing women, or individuals with darker skin. HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide. Redness, peeling, burning, dryness and itching may occur. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided.
For more information about Tri-Luma® Cream, see Full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Medwatch, or call 1-800-FDA-1088.
Legal | Privacy | Prescribing Information
Galderma Laboratories, L.P.United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.
Galderma Laboratories, L.P.United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.
Important Safety Information
Tri-Luma® Cream should be used with measures for sun avoidance, like using strong sunscreens. People allergic to sulfites should not use Tri-Luma® Cream. Tri-Luma® contains hydroquinone, which may cause a gradual blue-black darkening of the skin. Safety and efficacy have not been established in pregnant or nursing women, or individuals with darker skin. HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide. Redness, peeling, burning, dryness and itching may occur. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided.
For more information about Tri-Luma® Cream, see Full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Medwatch, or call 1-800-FDA-1088.
Tri-Luma® Cream should be used with measures for sun avoidance, like using strong sunscreens. People allergic to sulfites should not use Tri-Luma® Cream. Tri-Luma® contains hydroquinone, which may cause a gradual blue-black darkening of the skin. Safety and efficacy have not been established in pregnant or nursing women, or individuals with darker skin. HPA axis (adrenal function) suppression may result from exposure to the topical corticosteroid, fluocinolone acetonide. Redness, peeling, burning, dryness and itching may occur. Exposure to sunlight, sunlamps, or UV light and extreme heat, wind, or cold should be avoided.
For more information about Tri-Luma® Cream, see Full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Medwatch, or call 1-800-FDA-1088.